Moreover, SFN combination with anti-cancer agents modulated various tumor suppressors, cyclins, MMPs, cadherins, anti-oxidant enzymes, stem cell markers, apoptotic regulators, etc., which lead to enhanced therapeutic outcomes of chemotherapeutics in cancer models both in vitro and in vivo. The gene discussed is PCNA; the disease is cancer.